EORTC and Immunocore announce enrolment of first patient onto the only active Phase 3 adjuvant trial in uveal melanoma
ATOM is the only active Phase 3 trial for [...]
EORTC SPRINT clinical cancer study receives support from Rising Tide Foundation to reduce the burden for patients
Brussels, 5 November 2024 – Rising Tide Foundation for [...]
Clinical Trials Day 2024: a Q&A on pragmatic clinical trials
Over the last ten years, Clinical Trials Day has [...]
Three new EORTC clinical trials funded by the EU
Brussels, April 24, 2023 - The European Commission has [...]
Important new results from EORTC to be presented at ESTRO 2023
Brussels, April 14, 2023 – Radiation oncology is among the main [...]
Stakeholders’ consensus response to the proposed European Health Data Space
On 29 November, EORTC joined a group of 35 [...]
EORTC and KHCC sign first Middle Eastern collaboration agreement
Brussels, 17 November 2022 - The European Organisation for Research [...]
EORTC PhD fellow Emma Willems addresses how do leaders of international non-profit organizations deal with resource pressures caused by the COVID-19 pandemic GalleryEORTC PhD fellow Emma Willems addresses how do leaders of international non-profit organizations deal with resource pressures caused by the COVID-19 pandemic
EORTC PhD fellow Emma Willems addresses how do leaders of international non-profit organizations deal with resource pressures caused by the COVID-19 pandemic
Since 1991, the EORTC Fellowship Program enables physicians, statisticians [...]
